Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOACT: Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis
NCT01204333Phase 3Terminated
- Start
- Sep 2011
- Primary completion
- Dec 2016
- Modality
- Therapeutic Enzymes
- Countries
- 6
01
Overview
A Phase 3 trial of tissue-plasminogen activator, urokinase in Cerebral venous thrombosis (CVT). Started Sep 2011; status: terminated.
02
Drugs
tissue-plasminogen activatorurokinase
03
Conditions
Cerebral venous thrombosis (CVT)
Beyond the preview
Go deeper on NCT01204333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01204333.